Co-published editorial

Patent analytics

Pharmaceuticals

Since first quarter 2006, most pharma companies have increased their patent portfolios. The realignment is most closely tied to differences in research intensity. View PDF

---

Co-published editorial

Management report

Outsourcing

There is no doubting that these days outsourcing is a multi-billion dollar business. And it is not hard to see why, as companies are in a position to save substantial amounts of money when they send out work to be done by third parties at a fraction of the amount it would cost for the same to be done in-house View PDF

---

Co-published editorial

Roundtable

The Asian perspective

Four experts from some of the leading firms in Asia and the Pacific Rim discuss key IP issues facing their jurisdictions View PDF

---

Co-published editorial

Industry insight

How to keep in shape and beat the competition

As companies strive for new sources of value creation, with many turning to their patent portfolios as an asset base for exploitation, CPA’s John Pryor looks at ways to stay ahead of the competition View PDF